Plan B Boosts Barr Branded Sales; Firm Teams With Teva On Generic Allegra
This article was originally published in The Tan Sheet
Executive Summary
Barr Labs expects an increase in Plan B prescription sales to contribute to the firm's growing revenues for its proprietary product portfolio